<DOC>
	<DOC>NCT00168948</DOC>
	<brief_summary>- intermittent preventive treatment with SP in children to evaluate efficacy and safety of this drug combination in children in northern Ghana</brief_summary>
	<brief_title>Intermittent Antimalaria Treatment With SP in African Children</brief_title>
	<detailed_description>- Sulfadoxine and pyrimethamine have long been used for malaria prevention and treatment. In this study, following suggestions of WHO, these drugs are used for intermittent treatment. - It will be tested if this approach reduces the number of malaria attacks and ameliorates the severity of the disease - It will also be determined if anemia due to malaria, which is prevalent in northern Ghana, may be reduced - Moreover, the interaction between red cell polymorphisms such as HbS, HbC, alpha-thalassemia and glucose-6-phosphate dehydrogenase deficiency and SP will be examined</detailed_description>
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Pyrimethamine</mesh_term>
	<criteria>informed consent by parents or guardian no concomitant serious disease age &gt;2 months serious allergy or hypersensitivity to sulfonamides or pyrimethamine no severe hepatic or renal dysfunction serious breach of study protocol</criteria>
	<gender>All</gender>
	<minimum_age>2 Months</minimum_age>
	<maximum_age>4 Months</maximum_age>
	<verification_date>February 2003</verification_date>
	<keyword>Intermittent preventive treatment</keyword>
	<keyword>IPTi</keyword>
	<keyword>Malaria control</keyword>
	<keyword>Ghana</keyword>
</DOC>